This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taguchi, A. Articles by Takahashi, T. Search for Related Content PubMed PubMed Citation Articles by Taguchi, A. Articles by Takahashi, T.

Identification of Hypoxia-Inducible Factor-1 as a Novel Target for miR-17-92 MicroRNA Cluster

¹ Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer and ² Department of Gastroenterology, Nagoya University Graduate School of Medicine; ³ Institute for Advanced Research, Nagoya University, Nagoya, Japan

Requests for reprints: Takashi Takahashi, Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Phone: 81-52-744-2454; Fax: 81-52-744-2457; E-mail: tak{at}med.nagoya-u.ac.jp.

Key Words: microRNA • lung cancer • HIF-1 • c-myc

MicroRNAs (miRNAs) are a distinct class of small noncoding RNAs that posttranscriptionally repress expression of target genes through imperfect base pairing with the 3' untranslated region. We previously reported amplification and overexpression of the miR-17-92 miRNA cluster at 13q31.3 in lung cancers, as well as growth inhibition by treatment with antisense oligonucleotides against miR-17-5p and miR-20a, constituents of miR-17-92, specifically in miR-17-92–overexpressing lung cancer cell lines. Although these findings clearly suggested important roles of miR-17-92 overexpression in lung cancers, only a few targets for the miR-17-92 cluster have been identified thus far. In this study, we identified hypoxia-inducible factor (HIF)-1 as a novel direct target for miR-17-92 through global expression profiling by mass spectrometric analysis using an isobaric tagging reagent, iTRAQ, combined with bioinformatic target prediction. This is the first report to describe negative regulation of HIF-1 by miRNA, which seemed to occur without disrupting the induction of HIF-1 for cellular adaptation to hypoxia. In addition, overexpression of c-myc led to down-regulation of HIF-1 and induction of miR-17-92, the latter of which was previously reported to be a transcriptional activation activity, suggesting that the induction of miR-17-92 may play a role at least in part in c-myc–mediated repression of HIF-1. Together with previous reports on the functional negative regulation of c-myc by HIF-1, our findings suggest the possible existence of an intricate and finely tuned circuit involving c-myc, miR-17-92, and HIF-1 that may play a role in cancer cell proliferation under normoxia in a cellular context–dependent manner. [Cancer Res 2008;68(14):5540–5]

This article has been cited by other articles:

				E K O Ng, W W S Chong, H Jin, E K Y Lam, V Y Shin, J Yu, T C W Poon, S S M Ng, and J J Y Sung Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening Gut, October 1, 2009; 58(10): 1375 - 1381. [Abstract] [Full Text] [PDF]

				E. M. C. Ohlsson Teague, C. G. Print, and M. L. Hull The role of microRNAs in endometriosis and associated reproductive conditions Hum. Reprod. Update, September 22, 2009; (2009) dmp034v1. [Abstract] [Full Text] [PDF]